Immune disturbance leads to pulmonary embolism in COVID-19 more than classical risk factors: a clinical and histological study
Sebastiano Cicco,Antonio Vacca,Federica Albanese,Nicola Susca,Vanessa Desantis,Arianna Magistro,Gerardo Cazzato,Gerolamo Cicco,Sara Sablone,Christel Cariddi,Marialuisa Sveva Marozzi,Cristiana Catena,Gabriele Brosolo,Stefano Marcante,Giuseppe Ingravallo,Lidia Dalfino,Gianfranco Lauletta,Fabrizio Pappagallo,Antonio Giovanni Solimando,Salvatore Grasso,Eugenio Maiorano,Francesco Introna,Leonardo Alberto Sechi,Roberto Ria
DOI: https://doi.org/10.1007/s11739-023-03383-9
Abstract:COVID-19 induces endotheliitis and one of the main complications is enhanced coagulation. The incidence of pulmonary embolism (PE) in COVID-19 (CPE) has increased and clinical features for a rigorous analysis still need to be determined. Thus, we evaluated the clinical characteristics in CPE and the immune infiltration that occurred. Between January 1 and December 31, 2021, 38 patients were affected by CPE (9 ICU, 19 males/19 females, 70.18 ± 11.24 years) out of 459 COVID-19 cases. Controls were subjects who were evaluated for PE between January 1 2015, and December 31, 2019 (92 patients, 9 ICU, 48 males/45 females, 69.55 ± 16.59 years). All patients underwent complete physical examination, pulmonary computed tomography, laboratory tests, D-dimer, and blood gas analysis. There were no differences in laboratory tests or D-dimer. In patients with CPE, pO2, alveolar-arterial oxygen difference (A-aDO2), oxygen saturation %, and the ratio between arterial partial pressure of oxygen (PaO2) and fraction of inspired oxygen (FiO2), P/F, were significantly increased. There were no differences in PaCO2. Platelet count was inversely correlated to P/F (r = - 0.389, p = 0.02) but directly to A-aDO2 (r = 0.699, p = 0.001) only in patients with CPE. Histology of lung biopsies (7 CPE/7 controls) of patients with CPE showed an increase in CD15+ cells, HMGB1, and extracellular MPO as a marker of NETosis, while no significant differences were found in CD3+, CD4+, CD8+, and intracellular MPO. Overall, data suggest that CPE has a different clinical setting. Reduced oxygen content and saturation described in Patients with CPE should not be considered a trustworthy sign of disease. Increased A-aDO2 may indicate that CPE involves the smallest vessels as compared to classical PE. The significant difference in NETosis may suggest the mechanism related to thrombi formation.